HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/5/F1435    most recent 00176.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Kirchheimer, C. Articles by Nowicki, S. Search for Related Content PubMed PubMed Citation Articles by Kirchheimer, C. Articles by Nowicki, S.

Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na⁺-K⁺-ATPase activity in the proximal tubule

¹Centro de Investigaciones Endocrinológicas (CEDIE-CONICET) and ²Departamento de Bioquímica Humana, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

Submitted 22 May 2006 ; accepted in final form 16 January 2007

Previous studies propose 20-hydroxyeicosatetraenoic acid (20-HETE), a major arachidonic acid metabolite of cytochrome P-450 (CYP), as a possible mediator of Na⁺-K⁺-ATPase inhibition by dopamine (DA). The aim of this study was to investigate the intracellular mechanisms involved in this effect and to elucidate the DA receptor associated with the 20-HETE pathway in the rat kidney. DA (10^–5 M) inhibited Na⁺-K⁺-ATPase activity in microdissected tubular segments to 59.4 ± 3.8% of control activity. This response was suppressed by the CYP4A inhibitor 17-octadecynoic acid (10^–6 M), which had no effect per se, thus confirming the participation of CYP arachidonic acid metabolites in DA-induced Na⁺-K⁺-ATPase inhibition. We next examined whether 20-HETE is involved in the signaling pathways triggered by either D₁ or D₂ receptors. Neither fenoldopam nor quinpirole (D₁ and D₂ agonists, respectively, both 10^–5 M) modified Na⁺-K⁺-ATPase activity when tried alone. However, coincubation of a threshold concentration of 20-HETE (10^–9 M) with fenoldopam resulted in a synergistic inhibition of Na⁺-K⁺-ATPase activity (66 ± 2% of control activity), while 20-HETE plus quinpirole had no effect. Furthermore, 20-HETE (10^–9 M) synergized with forskolin (10^–5 M) and with the diacylglycerol analog 1-oleoyl-2-acetoyl-sn-glycerol (OAG; 10^–11 M; 62.0 ± 5.3 and 69.9 ± 2.0% of control activity, respectively), indicating a cooperative role of 20-HETE with the D₁-triggered pathways. In line with these results, no additive effect was observed when OAG and 20-HETE were combined at concentrations which per se produced maximal inhibition (10^–6 M). These results demonstrate that the inhibition of Na⁺-K⁺-ATPase activity by DA in the proximal tubule may be the result of the synergism between 20-HETE and the D₁ signaling pathway.

kidney

This article has been cited by other articles:

				C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF]